Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ ...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ 120MG BASE
USFDA APPLICATION NUMBER - 204168
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ ...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ 20MG BASE
USFDA APPLICATION NUMBER - 204168
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ ...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ 40MG BASE
USFDA APPLICATION NUMBER - 204168
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ ...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ 80MG BASE
USFDA APPLICATION NUMBER - 204168
Related Excipient Companies
Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Coating Systems & Additives
Controlled & Modified Release
Fillers, Diluents & Binders
Film Formers & Plasticizers
Granulation
Solubilizers
Direct Compression
Taste Masking
Coloring Agents
Empty Capsules
Thickeners and Stabilizers
Vegetarian Capsules
Parenteral
API Stability Enhancers
Lubricants & Glidants
Co-Processed Excipients
Disintegrants & Superdisintegrants
Emulsifying Agents
Rheology Modifiers
Chewable & Orodispersible Aids
Surfactant & Foaming Agents
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Levomilnacipran Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levomilnacipran Hydrochloride, including repackagers and relabelers. The FDA regulates Levomilnacipran Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levomilnacipran Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levomilnacipran Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levomilnacipran Hydrochloride supplier is an individual or a company that provides Levomilnacipran Hydrochloride active pharmaceutical ingredient (API) or Levomilnacipran Hydrochloride finished formulations upon request. The Levomilnacipran Hydrochloride suppliers may include Levomilnacipran Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Levomilnacipran Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Levomilnacipran Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Levomilnacipran Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Levomilnacipran Hydrochloride DMFs exist exist since differing nations have different regulations, such as Levomilnacipran Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Levomilnacipran Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Levomilnacipran Hydrochloride USDMF includes data on Levomilnacipran Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Levomilnacipran Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Levomilnacipran Hydrochloride suppliers with USDMF on PharmaCompass.
A Levomilnacipran Hydrochloride written confirmation (Levomilnacipran Hydrochloride WC) is an official document issued by a regulatory agency to a Levomilnacipran Hydrochloride manufacturer, verifying that the manufacturing facility of a Levomilnacipran Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Levomilnacipran Hydrochloride APIs or Levomilnacipran Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Levomilnacipran Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Levomilnacipran Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Levomilnacipran Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Levomilnacipran Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Levomilnacipran Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Levomilnacipran Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Levomilnacipran Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Levomilnacipran Hydrochloride suppliers with NDC on PharmaCompass.
Levomilnacipran Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levomilnacipran Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levomilnacipran Hydrochloride GMP manufacturer or Levomilnacipran Hydrochloride GMP API supplier for your needs.
A Levomilnacipran Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Levomilnacipran Hydrochloride's compliance with Levomilnacipran Hydrochloride specifications and serves as a tool for batch-level quality control.
Levomilnacipran Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Levomilnacipran Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levomilnacipran Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Levomilnacipran Hydrochloride EP), Levomilnacipran Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levomilnacipran Hydrochloride USP).
LOOKING FOR A SUPPLIER?
